Literature DB >> 14699551

Massachusetts General Hospital/Harvard Medical School MD oral and maxillofacial surgery program: a 30-year review.

Thomas B Dodson1, Walter C Guralnick, R Bruce Donoff, Leonard B Kaban.   

Abstract

PURPOSE: The first resident enrolled in the Massachusetts General Hospital/Harvard MD Oral and Maxillofacial Surgery (MD/OMFS) program graduated from Harvard Medical School (HMS) in 1972. The purpose of this report is to provide a summary of the first 30 years of the program and to outline plans for its future.
MATERIALS AND METHODS: This was a retrospective cohort study and the sample was composed of the residents enrolled in the MD/OMFS program between 1971 and 2000. Study variables included the dental school from which the resident graduated, successful completion of the MD/OMFS program, performance on parts I and II of the United States Medical Licensing Examination/National Board of Medical Examinations (USMLE/NBME), HMS grades, and career trajectories (full- or part-time academic or private practice). Appropriate descriptive and bivariate statistics were computed for all study variables.
RESULTS: During the study interval, 56 residents entered the MD/OMFS program and graduated from HMS. All members of the cohort, regardless of the dental school from which they graduated, performed well as evidenced by USMLE/NBME scores and medical school grades. Ninety-four percent of eligible graduates have completed the American Board of Oral and Maxillofacial Surgery examination. The pass rate was 100%. Thirty-four graduates are involved in full- or part-time academic practice. Four trainees completed medical school but did not complete the OMFS program.
CONCLUSION: The overwhelming majority of trainees completed the program, became board certified, and currently practice OMFS or a related specialty. A disproportionate number entered academic careers.

Entities:  

Mesh:

Year:  2004        PMID: 14699551     DOI: 10.1016/j.joms.2002.12.002

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  5 in total

1.  Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.

Authors:  Yuwei Wang; Alexandra Panasiuk; David W Grainger
Journal:  Mol Pharm       Date:  2011-01-21       Impact factor: 4.939

2.  Knowledge, attitude and awareness of speciality of oral and maxillofacial surgery amongst medical consultants of vadodara district in gujarat state.

Authors:  Navin Shah; Nameeta Patel; Amit Mahajan; Rishabh Shah
Journal:  J Maxillofac Oral Surg       Date:  2013-10-12

Review 3.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

4.  Who are we? A qualitative evaluation of trainees' perspectives on professional identity in oral and maxillofacial surgery.

Authors:  Arpan Tahim
Journal:  Perspect Med Educ       Date:  2015-02

5.  Privileges.

Authors:  Mukund Jagannathan
Journal:  Indian J Plast Surg       Date:  2016 Jan-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.